title: Increased transcript level of RBM3, a member of the glycine-rich RNA-binding protein family, in human cells in response to cold stress.
abstract: Although the cold-shock responses of microorganisms have been extensively investigated, those of mammalian cells are just beginning to be understood. Recently, CIRP, a member of the glycine-rich RNA-binding protein (GRP) family, has been identified as the first cold-shock protein in mammalian cells. Here, we report that RBM3, another member of the GRP family, is induced in human cells in response to cold stress (32 degrees C). RBM3 transcripts were constitutively expressed in all cell lines examined including K562, HepG2, NC65, HeLa, and T24 cells. In all of them, the transcript levels of RBM3 were increased at 24 h after the 37 to 32 degrees C temperature down-shift. In NC65 cells, the kinetics of RBM3 induction was different from that of CIRP. Protein synthesis inhibitors cycloheximide and puromycin induced RBM3 transcripts, but cadmium chloride, H2O2, ethanol, and osmotic shock had no effect. Combined with the different tissue distribution of expression, these results suggest that RBM3 and CIRP play distinct roles in cold responses of human cells.
authors.affiliation: Department of Clinical Molecular Biology, Faculty of Medicine, Kyoto University, Sakyo-ku, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Danno
authors.forename: H
authors.initials: H
authors.lastname: Nishiyama
authors.forename: H
authors.initials: H
authors.lastname: Higashitsuji
authors.forename: H
authors.initials: H
authors.lastname: Yokoi
authors.forename: J H
authors.initials: JH
authors.lastname: Xue
authors.forename: K
authors.initials: K
authors.lastname: Itoh
authors.forename: T
authors.initials: T
authors.lastname: Matsuda
authors.forename: J
authors.initials: J
authors.lastname: Fujita
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D003080:Cold Temperature; D003513:Cycloheximide / Q000494:pharmacology; D006367:HeLa Cells / Q000378:metabolism; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism; D007700:Kinetics; D007938:Leukemia / Q000378:metabolism; D008113:Liver Neoplasms / Q000378:metabolism; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis*; D016601:RNA-Binding Proteins / Q000235:genetics*; D014018:Tissue Distribution; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms / Q000378:metabolism
chemical_list: D011500:Protein Synthesis Inhibitors; C099506:RBM3 protein, human; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D011691:Puromycin; D003513:Cycloheximide